Gut microbiota and colorectal cancer: mechanistic insights, diagnostic advances, and microbiome-based therapeutic strategies
Frontiers in Microbiology · 20.11.2025 · 16
DOI: 10.3389/fmicb.2025.1699893 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 20.11.2025. Verfasst von Bingbing Bai und 14 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center (CRC), Medical Pathology Center (MPC), Cancer Early Detection and Treatment Center (CEDTC) and Translational Medicine Resear…. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Colorectal cancer (CRC) is closely linked to gut microbiota dysbiosis. We synthesize evidence that carcinogenic microbes promote CRC through chronic inflammation, bacterial genotoxins, and metabolic imbalance, highlighting key pathways involving Fusobacterium nucleatum , pks + Escherichia coli , and enterotoxigenic Bacteroides fragilis (ETBF). Building on these mechanisms, we propose a minimal diagnostic signature that integrates multi-omics with targeted qPCR, and a pathway–therapy–microbiome matching framework to guide individualized treatment. Probiotics, fecal microbiota transplantation (FMT), and bacteriophage therapy show promise as adjunctive strategies; however, standardization, safety monitoring, and regulatory readiness remain central hurdles. We advocate a three-step path to clinical implementation—stratified diagnosis, therapy matching, and longitudinal monitoring—supported by spatial multi-omics and AI-driven analytics. This approach aims to operationalize microbiome biology into deployable tools for risk stratification, treatment selection, and surveillance, advancing toward microbiome-informed precision oncology in CRC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Research Center (CRC), Medical Pathology Center (MPC), Cancer Early Detection and Treatment Center (CEDTC) and Translational Medicine Research Center (TMRC), Chongqing University Three Gorges Hospital, Chongqin…
- CQU-Ferenc Krausz Nobel Laureate Scientific Workstation, Chongqing University Three Gorges Hospital and Academy for Advanced Interdisciplinary Technology, Chongqing, China.
- Chongqing Technical Innovation Center for Quality Evaluation and Identification of Authentic Medicinal Herbs, Chongqing, China.
- School of Medicine, Chongqing University, Chongqing, China.
- State Key Laboratory of Digital Medical Engineering, Key Laboratory of Biomedical Engineering of Hainan Province, School of Biomedical Engineering, Hainan University, Sanya, Hainan, China.
- West China School of Basic Medical Sciences and Forensic Medicine, Institute of Biomedical Engineering, Sichuan University, Chengdu, China.
Zitieren
APA
Bai, B., Ma, J., Xu, W., Chen, X., Chen, X., Lv, C., Su, W., Li, Y., Sun, H., Zhang, B., Xiang, D., Li, Z., Wu, Y., Sun, J., & Yin, M. (2025). Gut microbiota and colorectal cancer: mechanistic insights, diagnostic advances, and microbiome-based therapeutic strategies. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1699893
Vancouver
Bai B, Ma J, Xu W, Chen X, Chen X, Lv C, et al. Gut microbiota and colorectal cancer: mechanistic insights, diagnostic advances, and microbiome-based therapeutic strategies. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1699893
BibTeX
@article{Bai2025,
author = {Bai, Bingbing and Ma, Jianing and Xu, Wenlong and Chen, Xiaomin and Chen, Xu and Lv, Chao and Su, Wei and Li, Yaoxu and Sun, Hongyin and Zhang, Baoyin and Xiang, Dejuan and Li, Zhongsha and Wu, Yuesong and Sun, Jian and Yin, Mingzhu},
title = {Gut microbiota and colorectal cancer: mechanistic insights, diagnostic advances, and microbiome-based therapeutic strategies},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1699893}
}
EUVIMED